These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1888227)

  • 1. Effect of activated charcoal on the disposition of sulphadoxine.
    Akintonwa A; Obodozie O
    Arch Int Pharmacodyn Ther; 1991; 309():185-92. PubMed ID: 1888227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteral exsorption of acetaminophen after intravenous injection in rats: influence of activated charcoal on this clearance path.
    Eyer F; Jung N; Neuberger H; Schulz R; Steiner K; Ladstetter B; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):163-71. PubMed ID: 17697035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
    Brahmi N; Kouraichi N; Thabet H; Amamou M
    Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
    Gude AB; Hoegberg LC; Angelo HR; Christensen HR
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves.
    Kaartinen L; Gips M; Laurila T; Härtel H; Soback S; Pyörälä S
    Vet Res; 2000; 31(5):517-26. PubMed ID: 11050747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
    North DS; Peterson RG; Krenzelok EP
    Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine adsorption by activated charcoal.
    Chinouth RW; Czajka PA; Peterson RG
    Vet Hum Toxicol; 1980 Dec; 22(6):392-4. PubMed ID: 7210465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorption of oral antidotes for acetaminophen poisoning (methionine and n-acetylcysteine) by activated charcoal.
    Klein-Schwartz W; Oderda GM
    Clin Toxicol; 1981 Mar; 18(3):283-90. PubMed ID: 7237961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.
    Campbell JW; Chyka PA
    Am J Emerg Med; 1992 May; 10(3):208-10. PubMed ID: 1586429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated charcoal adsorbs aflatoxin B1.
    Decker WJ; Corby DG
    Vet Hum Toxicol; 1980 Dec; 22(6):388-9. PubMed ID: 6782748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adsorption of metronidazole and tinidazole to activated charcoal and the effect of magnesium sulfate.
    Akintonwa A; Orisakwe OE
    Vet Hum Toxicol; 1988 Dec; 30(6):556-8. PubMed ID: 3245120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of activated charcoal on isoniazid absorption in rabbits.
    Ofoefule SI; Onuoha LC; Okonta MJ; Udeogaranya PO; Orisakwe OE
    Boll Chim Farm; 2001; 140(3):183-6. PubMed ID: 11486611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate.
    Gadgil SD; Damle SR; Advani SH; Vaidya AB
    Cancer Treat Rep; 1982 May; 66(5):1169-71. PubMed ID: 7083219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.